Access brought to you by: LOCKSS

Cardiology & Cardiovascular Medicine

SORT-OUT VI: Zotarolimus-Eluting Stent Noninferior to Biolimus-Eluting Stent
TOPCAT: Effects of Spironolactone on CV Outcomes in Patients with Heart Failure with Preserved Ejection Fraction
Prehospital Bivalirudin Improved Outcomes versus Heparin in Patients with Myocardial Infarction
Adverse Effects Associated with Varespladib in the VISTA-16 Trial
Similar Outcomes with Two-Stent and Provisional Stenting Techniques in Large Side Branch Bifurcation Lesions
Endovascular Revascularization Plus Supervised Exercise May Benefit Intermittent Claudication Patients
Tryton Two-Stent Strategy Safe, but Did Not Meet Noninferiority Endpoint
EU-PACT Study: Initial Warfarin Dosing Improved by Clinical Variables and Genotype to Guide Therapy
No Change in Thrombotic Risk with Short-Term DAPT after Stenting
COAG Trial: No Advantage Seen with Genetic-Based Warfarin Dosing

Pages